Osaic Holdings
DSGN icon

Osaic Holdings’s Design Therapeutics DSGN Stock Holding History

Osaic Holdings’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.25K Sell
225
-81
-26% -$1.01K ﹤0.01% 7108
2026
Q1 		$3.26K Buy
306
+296
+2,960% +$3K ﹤0.01% 6867
2025
Q4 		$94 Buy
+10
New +$78 ﹤0.01% 7656
2025
Q3 		– Sell
-10
Closed -$34 – 7919
2025
Q2 		$34 Sell
10
-39
-80% -$146 ﹤0.01% 7640
2025
Q1 		$189 Sell
49
-24
-33% -$115 ﹤0.01% 7171
2024
Q4 		$450 Buy
73
+63
+630% +$365 ﹤0.01% 7042
2024
Q3 		$54 Buy
+10
New +$47 ﹤0.01% 7291
2024
Q1 		– Sell
-15
Closed -$35 – 7241
2023
Q4 		$35 Sell
15
-200
-93% -$458 ﹤0.01% 7182
2023
Q3 		$505 Sell
215
-17
-7% -$79 ﹤0.01% 6986
2023
Q2 		$1.46K Buy
232
+29
+14% +$177 ﹤0.01% 6766
2023
Q1 		$1.17K Sell
203
-17
-8% -$127 ﹤0.01% 6897
2022
Q4 		$2K Sell
220
-101
-31% -$1.37K ﹤0.01% 6635
2022
Q3 		$5K Buy
321
+88
+38% +$1.75K ﹤0.01% 6350
2022
Q2 		$4K Hold
233
– – ﹤0.01% 6575
2022
Q1 		$4K Buy
233
+28
+14% +$429 ﹤0.01% 6584
2021
Q4 		$5K Buy
205
+109
+114% +$1.87K ﹤0.01% 6621
2021
Q3 		$2K Hold
96
– – ﹤0.01% 6840
2021
Q2 		$2K Buy
96
+60
+167% +$1.51K ﹤0.01% 6693
2021
Q1 		$1K Buy
+36
New +$1.21K ﹤0.01% 6633

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's DSGN Position: Q2 2026 in Review

Osaic Holdings reduced its Design Therapeutics (DSGN) stake by 26% in Q2 2026, selling an estimated $1.01K and leaving 225 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #7108.

Osaic Holdings first reported a position in DSGN in Q1 2021 and has held it in 19 quarters since. The position peaked at $5K in Q3 2022. 136 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Osaic Holdings held 225 shares of Design Therapeutics worth $3.25K as of Q2 2026.
  • Osaic Holdings sold 81 Design Therapeutics shares in Q2 2026, an estimated $1.01K.
  • Design Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7108 holding.
  • Osaic Holdings first reported a position in Design Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • Osaic Holdings's Design Therapeutics position peaked at $5K in Q3 2022.
  • 136 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.